(Q33476250)
Statements
Phase I clinical investigation of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate (NSC 312887), a new purine antimetabolite (English)
J. J. Hutton
D. D. Von Hoff
J. Kuhn
J. Phillips
M. Hersh
1 September 1984